Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

NCT05764265 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
31
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor Decision

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals